West Pharmaceutical Services | WST - Betriebsaufwand

Aktienkurs
243.37
Täglich Wechseln
6.34 2.67%
Monatlich
-0.35%
Jährlich
6.42%
Q1 Prognose
229.92




Betriebsaufwand Veränderung Datum
Align Technology USD 822.85M 11.8M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dentsply International USD 423M 1.06B 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
J&J USD 18.97B 2.38B 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Neogen USD 230.07M 4.79M 2025-09
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Rockwell Medical USD 30.41M 1.11M 2025-06
Solventum Corp USD 1.89B 3.09B 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Utah Medical Products USD 6.25M 80K 2024-09
West Pharmaceutical Services USD 642.5M 2.41B 2025-12